Acorah Software Products - Accounts Production 16.2.850 false true 5 April 2024 6 April 2023 false 6 April 2024 5 April 2025 5 April 2025 14232694 Mr Andrew Pieri iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14232694 2024-04-05 14232694 2025-04-05 14232694 2024-04-06 2025-04-05 14232694 frs-core:CurrentFinancialInstruments 2025-04-05 14232694 frs-core:FurnitureFittings 2025-04-05 14232694 frs-core:FurnitureFittings 2024-04-06 2025-04-05 14232694 frs-core:FurnitureFittings 2024-04-05 14232694 frs-core:ShareCapital 2025-04-05 14232694 frs-core:RetainedEarningsAccumulatedLosses 2025-04-05 14232694 frs-bus:PrivateLimitedCompanyLtd 2024-04-06 2025-04-05 14232694 frs-bus:FilletedAccounts 2024-04-06 2025-04-05 14232694 frs-bus:SmallEntities 2024-04-06 2025-04-05 14232694 frs-bus:AuditExempt-NoAccountantsReport 2024-04-06 2025-04-05 14232694 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-06 2025-04-05 14232694 frs-core:UnlistedNon-exchangeTraded 2025-04-05 14232694 frs-core:UnlistedNon-exchangeTraded 2024-04-05 14232694 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-04-05 14232694 frs-core:AdditionsToInvestments frs-core:UnlistedNon-exchangeTraded 2025-04-05 14232694 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2025-04-05 14232694 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-04-05 14232694 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2025-04-05 14232694 frs-bus:Director1 2024-04-06 2025-04-05 14232694 frs-bus:Director1 2024-04-05 14232694 frs-bus:Director1 2025-04-05 14232694 frs-countries:EnglandWales 2024-04-06 2025-04-05 14232694 2023-04-05 14232694 2024-04-05 14232694 2023-04-06 2024-04-05 14232694 frs-core:CurrentFinancialInstruments 2024-04-05 14232694 frs-core:ShareCapital 2024-04-05 14232694 frs-core:RetainedEarningsAccumulatedLosses 2024-04-05
Registered number: 14232694
Andrew Pieri Limited
Unaudited Financial Statements
For The Year Ended 5 April 2025
Sharpe Medical Accounting Ltd
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 14232694
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 2,158 1,795
Investments 5 320,000 -
322,158 1,795
CURRENT ASSETS
Debtors 6 553,662 106,625
Cash at bank and in hand 9,711 308,859
563,373 415,484
Creditors: Amounts Falling Due Within One Year 7 (175,997 ) (117,877 )
NET CURRENT ASSETS (LIABILITIES) 387,376 297,607
TOTAL ASSETS LESS CURRENT LIABILITIES 709,534 299,402
NET ASSETS 709,534 299,402
CAPITAL AND RESERVES
Called up share capital 8 200 200
Profit and Loss Account 709,334 299,202
SHAREHOLDERS' FUNDS 709,534 299,402
Page 1
Page 2
For the year ending 5 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Andrew Pieri
Director
14/07/2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Andrew Pieri Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14232694 . The registered office is C/O Sharpe Medical Accounting Limited, Normanby Gateway, Lysaghts Way, Scunthorpe, North Lincolnshire, DN15 9YG.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is recognised when a company gains entitlement to receive income from a third party.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings 20% Straight Line
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Tangible Assets
Fixtures & Fittings
£
Cost
As at 6 April 2024 2,306
Additions 899
As at 5 April 2025 3,205
Depreciation
As at 6 April 2024 511
Provided during the period 536
As at 5 April 2025 1,047
Net Book Value
As at 5 April 2025 2,158
As at 6 April 2024 1,795
5. Investments
Unlisted
£
Cost
As at 6 April 2024 -
Additions 320,000
As at 5 April 2025 320,000
Provision
As at 6 April 2024 -
As at 5 April 2025 -
Net Book Value
As at 5 April 2025 320,000
As at 6 April 2024 -
Page 4
Page 5
6. Debtors
2025 2024
£ £
Due within one year
Prepayments and accrued income 8,620 312
Other debtors 100,893 106,313
Director's loan account 4,278 -
Amounts owed by associates 439,871 -
553,662 106,625
7. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Corporation tax 139,902 95,519
Net wages 8,020 1,095
Accruals and deferred income 28,075 17,823
Director's loan account - 3,440
175,997 117,877
8. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 200 200
9. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 6 April 2024 Amounts advanced Amounts repaid Amounts written off As at 5 April 2025
£ £ £ £ £
Mr Andrew Pieri - 4,278 - - 4,278
The above loan is unsecured, interest free and repayable on demand.
Page 5